Investigation Overview
An investigation on behalf of investors of Obalon Therapeutics Inc (NASDAQ:OBLN) shares over potential securities laws violations by Obalon Therapeutics and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Obalon Therapeutics Inc ...
You must register (for free) or login to view the entire investigation.